黃芩湯首載于《傷寒論》，由黃芩Scutellariae Radix、白芍Paeoniae Radix Alba、甘草Glycyrrhizae Radix et Rhizoma和大棗Jujubae Fructu 4味中藥組成。黃芩湯組方精妙、效專力宏，傳承千年，至今仍在臨床應(yīng)用中發(fā)揮重要作用，具有廣闊的開發(fā)應(yīng)用前景。國家針對古代經(jīng)典名方的研究發(fā)布了一系列的支持政策，黃芩湯于2023年被收錄于國家中醫(yī)藥管理局公布的《古代經(jīng)典名方目錄（第2批）》，該方的研發(fā)受到國家的大力支持。為深入探索黃芩湯的現(xiàn)代研究進(jìn)展，推動經(jīng)典名方的創(chuàng)新研發(fā)，對近年來黃芩湯的化學(xué)成分、藥理作用、臨床應(yīng)用、制劑研究等進(jìn)行全面分析，為黃芩湯及經(jīng)典名方的現(xiàn)代研究提供科學(xué)依據(jù)。

Huangqin Decoction (黃芩湯, HQD) was first recorded in the Treatise on Typhoid Fever. It is composed of four kinds of traditional Chinese medicines: Huangqin (Scutellariae Radix), Baishao (Paeoniae Radix Alba), Gancao (Glycyrrhizae Radix et Rhizoma), Dazao (Jujubae Fructu). The prescription of HQD is exquisite and effective, which has been handed down for thousands of years and still plays an important role in clinical application. The Chinese government has issued a series of support policies for the study of ancient classical prescriptions. HQD was included in the Catalogue of Ancient Classical Prescriptions (second batch), published by the State Administration of Traditional Chinese Medicine publication in 2023, its research and development has obtained the strategic support of the country. To further explore the advancements in modern research on HQD and promote the innovation and development of classical prescriptions, this study comprehensively analyzes the chemical composition, pharmacological effects, clinical applications, and preparation research of HQD in recent years. This provides a solid scientific foundation for the modern study of HQD and classical prescriptions.

R285

四川省大學(xué)生創(chuàng)新創(chuàng)業(yè)訓(xùn)練計(jì)劃（S202410633023）